[1] From Weight Loss to Cosmetics: The Re-purposing of AOD-9604 Following the somewhat disappointing results from the weight loss trials, a new opportunity arose for AOD-9604 in 2009
Side Effects and the Copper Uglies Explained GHK-Cu has a strong safety profile in topical research, but a small subset of users experience a transient phase known as the copper uglies. A 2023 clinical safety review covering 12 studies and 512 participants reported that the most common side effects of topical GHK-Cu were transient and mild
Bioglutide (NA-931) Phase 2: 13.8% Oral Weight Loss The Phase 2 trial reported oral quadruple agonist NA-931 hit 13.8% weight loss with no muscle loss
They tend to disappear within a day or two
Despite this relatively short half-life in circulation, the downstream metabolic effects persist for significantly longer due to the sustained activation of lipolytic enzymes and metabolic pathways initiated by the peptide
Supports Red Blood Cell & Nerve Health Essential in preventing and treating anemia, neuropathy, numbness, and tingling by ensuring adequate red blood cell production and maintaining healthy nerve function
